Chapter 5. Neuroblastoma

  1. Ross Pinkerton1,
  2. Katherine Matthay3,
  3. AG Shankar2 and
  4. Katherine Matthay3
  1. Katherine Matthay

Published Online: 4 OCT 2007

DOI: 10.1002/9780470987148.ch5

Evidence-based Pediatric Oncology, Second Edition

Evidence-based Pediatric Oncology, Second Edition

How to Cite

Matthay, K. (2007) Neuroblastoma, in Evidence-based Pediatric Oncology, Second Edition (eds R. Pinkerton, K. Matthay, A. Shankar and K. Matthay), Blackwell Publishing, Oxford, UK. doi: 10.1002/9780470987148.ch5

Editor Information

  1. 1

    Childrens Cancer Unit, Mater Childrens Hospital, Raymond Terrace, Brisbane, Australia

  2. 2

    Department of Paediatric and Adolescent Oncology, University College of London NHS Trust, London, UK

  3. 3

    Department of Pediatric Oncology, University of California at San Francisco, San Francisco, CA, USA

Publication History

  1. Published Online: 4 OCT 2007
  2. Published Print: 13 APR 2007

ISBN Information

Print ISBN: 9781405142687

Online ISBN: 9780470987148

SEARCH

Keywords:

  • dose intensification;
  • therapy resistance;
  • autologous bone marrow transplantation (ABMT);
  • chemotherapy;
  • european neuroblastoma study group (ENSG)

Summary

This chapter contains sections titled:

  • Dose intensification to overcome resistance to therapy

  • Overcoming drug resistance with agents using new mechanisms of action

  • Local control

  • Minimal residual disease

  • Acute and late effects of therapy

  • Questions for future studies

  • Study 1

  • Study 2

  • Study 3

  • Study 4

  • Study 5

  • Study 6

  • Study 7

  • Study 8